Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
Thought Leadership
Dec 16, 2022
What to Expect from AI-Enabled Drug Discovery in 2023
Thought Leadership
Sep 7, 2022
The Evolution of Therapeutic Drug Monitoring for Tacrolimus
Thought Leadership
Jul 18, 2022
Understanding Project Optimus
Thought Leadership
Jul 13, 2022
Project Optimus for Oncology
Thought Leadership
Apr 6, 2022
Understanding FDA’s Perspective On Precision Dosing
Product Innovation
Apr 5, 2022
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
Scientific Publications
Mar 27, 2022
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
Scientific Publications
Mar 25, 2022
Model-Based Tacrolimus Follow-Up Dosing in Adult Renal Transplant Recipients: A Simulation Trial
Product Innovation
Mar 25, 2022
Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
3
4
5
6
7
